Taken together, these data suggest that cumulative immunogenic cell death during SFRT-GRID drives cancer cell clearance, and thus SFRT-GRID, but not WTRT, may potentiate immune-mediated tumor control (Fig. 8). This evidence concerns the gene GRAP2 and neoplasm.